XM无法为美国居民提供服务。
P
P

Pfizer


市场新闻

Moderna fends off Alnylam US patent lawsuit over COVID shots, for now

Moderna fends off Alnylam US patent lawsuit over COVID shots, for now By Blake Brittain Oct 2 (Reuters) - Alnylam Pharmaceuticals ALNY.O admitted defeat, for now, in a lawsuit in Delaware federal court that accused Moderna's MRNA.O blockbuster COVID-19 vaccines of infringing one of its patents. Alnylam and Moderna told U.S. District Judge Colm Connolly in a joint filing on Wednesday that Alnylam could not win its case after the judge interpreted part of the patent in a way that favored Moderna.
P

WHO recommends maternal vaccine and antibody shot to prevent RSV in infants

UPDATE 1-WHO recommends maternal vaccine and antibody shot to prevent RSV in infants Adds comments from WHO press conference in paragraphs 7 to 10 By Kashish Tandon and Bhanvi Satija Oct 1 (Reuters) - The World Health Organization on Tuesday recommended vaccinating pregnant women and administering infants with an antibody to prevent severe respiratory synctial virus (RSV) infection in newborns.
A
G
P
S

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Berkshire Hathaway, Brembo, Macquarie, SumUp; Updates: PepsiCo Oct 1 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1945 GMT on Tuesday: ** Berkshire Hathaway BRKa.N will take full ownership of Berkshire Hathaway Energy, after Warren Buffett's conglomerate agreed to acquire the 8% it did not already own from the family of late billionaire philanthropist Walter Scott.
B
N
P
P
Q
R
I
P

WHO recommends maternal shot and antibody therapy to prevent RSV in infants

WHO recommends maternal shot and antibody therapy to prevent RSV in infants Oct 1 (Reuters) - The World Health Organization on Tuesday recommended maternal vaccination and the use of an antibody therapy to prevent respiratory synctial virus (RSV) in infants. The recommendations, to administer both the shot and the antibody or either, come after the WHO's strategic advisory group on immunization met last week.
A
G
P
S

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Oct 1 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Tuesday: ** Dutch crop trader Louis Dreyfus raised its buyout offer for Namoi Cotton, with its bid that values the Australian cotton ginning firm at A$159.3 million ($110 million), signalling the end of a months-long bidding war as Singapore's Olam Agri effectively surrendered arms.
N
P
P
Q
R
I

UK Stocks-Factors to watch on Oct 1

UPDATE 1-UK Stocks-Factors to watch on Oct 1 Adds new items, updates futures Oct 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher, with futures FFIc1 up 0 .4%. * HALEON: Pfizer PFE.N offloaded shares worth roughly $3.26 billion in Haleon HLN.L at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said.
A
G
P
R

Europe before the bell: futures steady, M&A on the radar

LIVE MARKETS-Europe before the bell: futures steady, M&A on the radar Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EUROPE BEFORE THE BELL: FUTURES STEADY, M&A ON THE RADAR European shares look set to steady on Tuesday following a negative finish to the third quarter on Monday, when warnings from Stellantis STLAM.MI , VW VOWG_p.DE and Aston Martin AML.L raised fresh concern ove
P
V
A
E
F
U
G

Haleon To Purchase Shares Worth 230 Mln Stg From Pfizer

BRIEF-Haleon To Purchase Shares Worth 230 Mln Stg From Pfizer Oct 1 (Reuters) - HALEON PLC HLN.L : HALEON PLC - UPDATE ON PURCHASE ALONGSIDE PFIZER OFFERING HALEON PLC - TO PURCHASE 60,526,315 SHARES FROM PFIZER HALEON PLC - PURCHASE PRICE £3.80 PER SHARE, TOTAL £230 MILLION Source text for Eikon: ID:nRSA3613Ga Further company coverage: HLN.L
P

Pfizer offloads $3.3 bln stake in Sensodyne-maker Haleon

Pfizer offloads $3.3 bln stake in Sensodyne-maker Haleon Oct 1 (Reuters) - Pfizer PFE.N offloaded shares worth roughly $3.26 billion in Haleon HLN.L at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on Tuesday. Reporting by Prerna Bedi in Bengaluru; Editing by Savio D'Souza
P

UK Stocks-Factors to watch on Oct 1

UK Stocks-Factors to watch on Oct 1 Oct 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher, with futures FFIc1 up 0.34% * HALEON: Pfizer's PFE.N stake sale in British consumer healthcare company Haleon HLN.L has been upsized by 100 million shares to 640 million shares worth about $3.25 billion with strong demand from investors, a bookrunner familiar with the offering said on Monday.
A
P

Bookrunner Says Haleon PLC ABB Sale Of Shares By Pfizer Inc Deal Upsized To 640MM Shares / C. USD 3.25bn

BRIEF-Bookrunner Says Haleon PLC ABB Sale Of Shares By Pfizer Inc Deal Upsized To 640MM Shares / C. USD 3.25bn Sept 30 (Reuters) - Bookrunner: BLOCK TRADE: HALEON PLC ABB (SECONDARY) SALE OF SHARES BY PFIZER INC - DEAL UPSIZED TO 640MM SHARES / C. USD 3.25BN - BOOKRUNNER BLOCK TRADE: HALEON PLC ABB SALE OF SHARES BY PFIZER INC - ORDERS BELOW GBP 3.
P

Bookrunner Says Haleon Secondary ABB's Sale Of Shares By Pfizer Books Are Covered

BRIEF-Bookrunner Says Haleon Secondary ABB's Sale Of Shares By Pfizer Books Are Covered Sept 30 (Reuters) - BOOKRUNNER: BLOCKTRADE- HALEON PLC ABB (SECONDARY) - SALE OF SHARES BY PFIZER INC; BOOKS ARE COVERED; FURTHER GUIDANCE TO FOLLOW - BOOKRUNNER Further company coverage: HLN.L
P

Haleon To Buy £230 Mln Worth Of Shares From Pfizer

BRIEF-Haleon To Buy £230 Mln Worth Of Shares From Pfizer Sept 30 (Reuters) - HALEON PLC HLN.L : HALEON PLC - PROPOSED PURCHASE ALONGSIDE PFIZER OFFERING HALEON PLC - TO PURCHASE £230 MILLION WORTH OF SHARES FROM PFIZER Source text for Eikon: ID:nRSd3182Ga Further company coverage: HLN.L
P

Pfizer to sell about $3.25 bln stake in Sensodyne-maker Haleon, bookrunner says

UPDATE 3-Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon Placing at a 3.3% discount to Haleon's last close Haleon to buy back 230 mln stg worth of shares from Pfizer Pfizer to remain top Haleon shareholder -LSEG data Updates dateline to Oct. 1, recasts with final pricing, shares, other details throughout By Shanima A Oct 1 (Reuters) - Pfizer PFE.N sold a stake in British consumer healthcare group Haleon HLN.L worth about $3.26 billion on Monday, cutting its shareholding in the m
G
G
P

Pfizer to offload about 5.9% stake in UK's Haleon, says bookrunner

Pfizer to offload about 5.9% stake in UK's Haleon, says bookrunner Sept 30 (Reuters) - Pfizer PFE.N intends to offload about 540 million shares in the British consumer healthcare company Haleon HLN.L , a bookrunner said on Monday. The proposed sale will reduce the top shareholder's interest in Sensodyne-maker Haleon to 16.2% from 22.6%. Reporting b
P

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: TPG, TotalEnergies, Chevron, Pfizer Updates: Marsh McLennan, Verizon Communications Sept 30 (Reuters) - The following bids, mergers, acquisitions, and disposals were reported by 1950 GMT on Monday: ** Pfizer PFE.N intends to sell about 540 million shares in British consumer healthcare company Haleon HLN.L , a bookrunner said on Monday, reducing the top shareholder's interest in the Sensodyne maker to 16.2%.
A
C
N
P
R
V
U

UK's MHRA Says Pfizer Limited Is Recalling All Distributed Batches Of Oxbryta 500 Mg Tablets

BRIEF-UK's MHRA Says Pfizer Limited Is Recalling All Distributed Batches Of Oxbryta 500 Mg Tablets Sept 30 (Reuters) - Pfizer Inc PFE.N : UK'S MHRA: PFIZER LIMITED IS RECALLING ALL DISTRIBUTED BATCHES OF OXBRYTA 500 MG TABLETS Source text for Eikon: [ID:] Further company coverage: PFE.N
P

Why gene therapy for sickle cell is slow to catch on with patients

INSIGHT-Why gene therapy for sickle cell is slow to catch on with patients By Deena Beasley LOS ANGELES, Sept 28 (Reuters) - Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain earlier this month. She is doing what she can to prevent the crippling attacks in her arms, legs and abdomen that are becoming more frequent.
N
P
V

U.S. Albemarle, Nasdaq, Salesforce

U.S. RESEARCH ROUNDUP-Albemarle, Nasdaq, Salesforce Sept 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Albemarle, Nasdaq and Salesforce, on Friday. HIGHLIGHTS * Agios Pharmaceuticals Inc AGIO.O : Leerink Partners cuts to market perform from outperform * Albemarle ALB.N : Jefferies cuts target price to $120 from $124 * Dollar General Corp DG.N : Citigroup cuts to sell from neutral * Nasdaq Inc NDAQ.O : RBC initia
A
C
C
C
D
E
N
P
S
T
D
A
C
C
U

Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say

UPDATE 1-Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say EMA raises concerns about deaths in Oxbryta trials Shares of Agios and Fulcrum rise after Pfizer's decision Adds FDA statement in paragraph 4 By Kashish Tandon and Christy Santhosh Sept 26 (Reuters) - Pfizer's PFE.N decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said.
N
P
V



商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明